Revenue Surge
Waterdrop Reports Strong Revenue Growth Driven by Artificial Intelligence and Increased Payouts
Anonymous
Key Points
1
Waterdrop said its refined AI models increased insurance conversion efficiency, driving a 32.3% quarter-over-quarter rise in newly acquired customers; insurance-related income also grew 16.4% sequentially.
2
Waterdrop Medical Crowdfunding had reached approximately 499 million cumulative donors by June 30, 2026, who had contributed RMB74.7 billion to support 3.82 million patients.
3
The E-Find platform had facilitated enrollment for 17,052 patients across 1,873 clinical-trial programs as of June 30, substantially expanding beyond the quarter’s reported activity of 1,540 newly enrolled patients and 255 corporate partners.
4
Waterdrop’s market profile remained highly discounted, with the stock trading at roughly 0.6 times sales, 0.48 times book value and a price-to-earnings ratio near 4.6; the company also reported total assets above $7.1 billion, equity above $5.15 billion and limited debt.
Waterdrop reported a strong second quarter in 2026, with net operating revenue jumping 72.8% year over year to RMB1.45 billion, Yahoo Finance said. Insurance-related income surged 80.5% to RMB1.33 billion, while operating profit rose 14.3% to RMB111.3 million. The company credited AI improvements in customer acquisition and insurance conversion for the gains.
Waterdrop declared a cash dividend of about $10.8 million and launched a new five-year renewable critical-illness policy that requires no health disclosure. Simply Wall Street reported the stock climbed roughly 5% to US$1.07 after earnings, marking the company's eighteenth consecutive profitable quarter.
AI Models Drive Customer Growth and Conversions
Waterdrop's refined artificial intelligence systems produced a 32.3% quarter-over-quarter jump in newly acquired customers, according to The Globe and Mail. The AI improvements also boosted insurance conversion efficiency and enhanced underwriting and service productivity. The Globe and Mail noted that core business leverage improved as the company scaled operations.
Medical Crowdfunding Reaches Nearly 500 Million Donors
Waterdrop Medical Crowdfunding had accumulated approximately 499 million cumulative donors by June 30, 2026, who contributed RMB74.7 billion to help 3.82 million patients. The platform continues to expand its reach across China's healthcare ecosystem. This massive donor base strengthens Waterdrop's position in the medical assistance market.
Clinical-Trial Platform Expands Patient Enrollment
Waterdrop's E-Find clinical-trial platform had facilitated enrollment for 17,052 patients across 1,873 trial programs as of June 30. In the second quarter alone, the platform enrolled 1,540 new patients and partnered with 255 corporate organizations. This expansion demonstrates growing demand for Waterdrop's healthcare technology services beyond insurance.
Stock Remains Deeply Discounted Despite Strong Results
Despite robust earnings growth, Waterdrop's stock trades at roughly 0.6 times sales, 0.48 times book value, and a price-to-earnings ratio near 4.6, Yahoo Finance reported. The company holds total assets above $7.1 billion and equity above $5.15 billion with limited debt. However, Bamboo Works warned that rapidly growing technical-services revenue and heavy AI investment spending may pressure profitability, while regulatory scrutiny over service fees substituting for capped commissions poses ongoing risks.
Sentiment
Mostly PositiveNEGATIVENEUTRALPOSITIVE
Publishers
19
Articles
37
Reach
56
A
AnonymousAuthor
